Thursday, October 13, 2011

Botox

http://www.sourcewatch.org/index.php?title=Allergan
Excerpt:

http://people.forbes.com/profile/david-e-i-pyott/3031
Excerpt:

David E.I. Pyott Chairman of the Board, President and Chief Executive Officer

Allergan, Inc.

Irvine ,  CA

Sector: HEALTHCARE  /  Drug Manufacturers - Other

Officer since January 1998

Lead Independent Director ,  Avery Dennison Corp.

Pasadena ,  CA

Sector: CONSUMER GOODS  /  Paper & Paper Products

Independent Director ,  Edwards Lifesciences Corporation

Irvine ,  CA

Sector: HEALTHCARE  /  Medical Appliances & Equipment

57 Years Old
DAVID E.I. PYOTT, 57, has been our Chief Executive Officer since January 1998 and in 2001 became Chairman of the Board. Mr. Pyott also served as our President from January 1998 until February 2006. As Chief Executive Officer, Mr. Pyott refocused our strategy on specialty pharmaceuticals, biotechnology and medical devices and has grown our franchises in ophthalmology, neurosciences, medical dermatology, medical aesthetics, urology, obesity intervention and other specialty markets. Previously, Mr. Pyott served as head of the Nutrition Division and a member of the Executive Committee of Novartis AG, a publicly-traded company focused on the research and development of products to protect and improve health and well-being, from 1995 until December 1997. From 1992 to 1995, Mr. Pyott was President and Chief Executive Officer of Sandoz Nutrition Corp., Minneapolis, Minnesota, a predecessor to Novartis AG, and General Manager of Sandoz Nutrition, Barcelona, Spain, from 1990 to 1992. Prior to that, Mr. Pyott held various positions within the Sandoz Nutrition group from 1980. Mr. Pyott is also the lead independent director of the board of Avery Dennison Corporation, a publicly-traded company focused on pressure-sensitive technology and self-adhesive solutions where he serves on its Compensation Committee and Nominating and Governance Committee, and Edwards Lifesciences Corporation, a publicly-traded company focused on products and technologies to treat advanced cardiovascular diseases, where he serves on its Audit and Public Policy Committee. Mr. Pyott is a former member of the board for Pacific LifeCorp and Pacific Mutual Holding Company, the parent companies of Pacific Life Insurance Company. Mr. Pyott is a member of the Directors? Board of The Paul Merage School of Business at the University of California, Irvine. Mr. Pyott serves on the board and the Executive Committee of the California Healthcare Institute, and serves on the board, Executive Committee and as Chairman of the International Affairs Committee of the Biotechnology Industry Organization. Mr. Pyott also serves as a member of the board of the Pan-American Ophthalmological Foundation, the International Council of Ophthalmology Foundation and as a member of the Advisory Board for the Foundation of The American Academy of Ophthalmology. Mr. Pyott also serves as Vice Chairman of the Board of Trustees of Chapman University. On March 7, 2011, the Company announced that its Board of Directors has reappointed David E.I. Pyott as President. Mr. Pyott will also continue to serve the Company in his current roles as Chairman of the Board and Chief Executive Officer. Mr. Pyott?s role as President succeeds the duties performed by Mr. Ball and will be effective March 27, 2011.

http://worldmeets.us/beijingnews000018.shtml#axzz1ahcqnAUc
Excerpt:
Bribery in China: The reporting of U.S. agencies on cases of
corruption in China and pressure from Internet users seems
to have embarrassed Beijing into a renewed crackdown.


The Beijing News, People's Republic of China
China Must Stop Relying on U.S. Justice to Halt Bribery

In this surprisingly self-critical article from China's state-controlled Xinjingbao [Beijing News], the author castigates the authorities for relying on foreign justice to identify graft - and for failing to pursue those who have taken bribes from American companies. Given the appearance of this article in the state-controlled press, one can assume that Beijing has been embarrassed into authorizing a renewed crackdown by disclosures from U.S. government agencies and Chinese Internet users.

By Ma Di-ming [马涤明] (A clerk from Inner Mongolia)

Translated By Ann Tang Kubusek

August 14, 2009

The wife of the governor of the Guizhou Province, just before her execution for embezzlement in 1995: While punishment for graft has not been the rule in mainland China, when there is a crackdown, the penalty is often death.

Bribing and taking bribes have corresponding relationships; so how can one see the briber without the bribee? In the words of one Internet user, you can't pull out the radishes without bringing the mud with it. So who exactly is the bribee?  

The chief officer at the Ministry of Public Security's Transportation Management and Science Research Institute has responded to allegations of bribery with the following, "The magnate of the adhesive glue industry, Avery Dennison, admits to bribing the Wuxi Public Security Bureau." The institute says it assigned staff specifically to conduct a detailed understanding and investigation to "make sure that no one accepted gifts and that other related expenses did not occur." The chief officer also extended his thanks to the media and Internet users for their supervision and support. (People Daily, Aug. 12).


http://worldmeets.us/ http://worldmeets.us/beijingnews000018.shtml#ixzz1ahdYVgm4

No comments:

Post a Comment